HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined hereditary factor XI (plasma thromboplastin antecedent) deficiency, von Willebrand's disease, and xeroderma pigmentosum in a Japanese family.

Abstract
We report a 28-year-old-Japanese male who had a skin tumor derived from variant type xeroderma pigmentosum (XP), combined with factor XI (FXI) deficiency and type IIB von Willebrand's disease (vWd). The patient had abnormal bleeding history on tooth extraction. FXI clotting activity (FXI:C) and antigen (FXI:Ag) were remarkably decreased (< 0.01 U/ml, < 0.02 U/ml, respectively). Factor VIII (FVIII) clotting activity, von Willebrand factor antigen (vWf:Ag), and ristocetin cofactor (RCoF) were 0.43 U/ml, 45%, and 57%, respectively. Ristocetin-induced platelet agglutination (RIPA) revealed hyper-aggregation compared with a normal control. Multimeric composition of vWf in plasma showed a reduction in high molecular weight forms. The family study revealed two other subjects with homozygous hereditary FXI deficiency and vWd, and five subjects with heterozygous FXI deficiency. The relationship between FXI deficiency and vWd is discussed and previously reported cases are reviewed.
AuthorsM Sano, H Saito, Y Shimamoto, I Sugiura, H Ohtsubo, H Kohda, M Yamaguchi
JournalAmerican journal of hematology (Am J Hematol) Vol. 44 Issue 2 Pg. 129-33 (Oct 1993) ISSN: 0361-8609 [Print] United States
PMID8266918 (Publication Type: Case Reports, Journal Article)
Chemical References
  • von Willebrand Factor
  • Ristocetin
  • Factor VIII
Topics
  • Adult
  • Asian People (genetics)
  • Blood Coagulation
  • Factor VIII (analysis)
  • Factor XI Deficiency (complications, epidemiology)
  • Family Health
  • Female
  • Heterozygote
  • Humans
  • Japan (epidemiology)
  • Male
  • Pedigree
  • Ristocetin (analysis)
  • Xeroderma Pigmentosum (complications, epidemiology)
  • von Willebrand Diseases (complications, epidemiology)
  • von Willebrand Factor (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: